Escalante v. California Physicians' Service

309 F.R.D. 612, 2015 U.S. Dist. LEXIS 97261, 2015 WL 4477721
CourtDistrict Court, C.D. California
DecidedJuly 14, 2015
DocketCase No. CV 14-03021 DDP (PJWx)
StatusPublished
Cited by6 cases

This text of 309 F.R.D. 612 (Escalante v. California Physicians' Service) is published on Counsel Stack Legal Research, covering District Court, C.D. California primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Escalante v. California Physicians' Service, 309 F.R.D. 612, 2015 U.S. Dist. LEXIS 97261, 2015 WL 4477721 (C.D. Cal. 2015).

Opinion

ORDER GRANTING PLAINTIFF LUIS ESCALANTE’S MOTION FOR CLASS CERTIFICATION

DEAN D. PREGERSON, United States District Judge

Presently before the Court is Plaintiff Luis Escalante (“Plaintiff’)’s Motion for Class Certification (the “Motion” or “Mot.”). (Dkt. Nos. 31, 36.) Having considered the parties’ submissions and heard oral argument, the Court GRANTS the motion and adopts the following order.

I. BACKGROUND

Plaintiff Luis Escalante was a member of a group health policy issued by Blue Shield of California (“Blue Shield” or “Defendant”). (Compl. ¶4, 15; Declaration of Luis Esca-lante (“Escalante Deck”), Dkt. No. 31-1, ¶ 2.) Defendant is a “health care service plan” licensed and regulated by the California Department of Managed Health Care (“DMHC”). (ComplV 6.)

Plaintiff suffers from degenerative disc disease. (Id. ¶ 16.) Plaintiff alleges that in December 2013, he consulted a board-certified neurosurgeon regarding his condition. (Id. ¶ 8.) Although lumbar fusion is a more traditional treatment for degenerative disc disease, Plaintiffs doctor recommended that he undergo artificial disc replacement (“ADR”) surgery instead. (Id. ¶¶ 8, 16-17; Escalante Deck ¶¶3^4.) As a consequence, Plaintiff requested authorization from Defendant to undergo ADR surgery. (Compl. ¶ 18; Escalante Deck ¶ 5.) On February 6, 2014, Defendant denied Plaintiffs authorization request. (Compl. ¶ 19.) Defendant’s denial letter stated that Plaintiffs request for coverage for the ADR surgery was not approved because “the efficacy of [ADR] has not been validated by the peer reviewed literature.” (Compl. Ex. 14.) Plaintiff alleges that he appealed the decision, and that, on March 12, 2014, his appeal was denied. (Compl. ¶ 20.)

Plaintiff, as a Blue Shield member, was provided with an Evidence of Coverage (“EOC”) document that excludes coverage for investigational procedures. (Compl. ¶ 7.) [616]*616An EOC is the contract between a health plan and a plan member that sets forth the terms and conditions of coverage, including descriptions of services that are excluded from coverage. (Id. ¶¶ 6-7.) Defendant considers ADR an excluded, investigational procedure under Blue Shield’s EOC. (Compl. Ex. 8 at 162; Allen Decl., Dkt. No. 40-9, ¶ 6.) Defendant defines “investigational” as:

Any treatment, therapy, procedure, drug or drug usage, facility or facility usage, equipment or equipment usage, device or device usage, or supplies which are not recognized in accordance with generally accepted professional medical standards as being safe and effective for use in the treatment of the illness, injury or condition at issue. (Compl. Exb. 5-6.)

Defendant’s policies state that ADR is inves-tigational because of a lack of “long-term efficacy and safety in comparison to standard spinal fusion techniques.” (Compl. Ex. 9 at 177, Ex. 10 at 194, Ex. 11 at 212.) Defendant therefore denies all requests and claims for ADR. (Compl. Ex. 7 at 131, 136-140, 142; Opp. at 1.) Defendant has considered ADR investigational since at least April 18, 2010. (Compl. Exh. 8 at 162; Allen Decl. ¶ 6.)

Defendant’s ADR policy is available on its health care provider website. (Compl. Ex. 7 at 127.) Health care providers can access the ADR policy to advise patients that ADR is considered investigational. (Id at 129.) Health plan members can also access this website. (Id. at 127.)

Defendant has submitted records showing it has denied 19 authorization requests for ADR between April 2010 and October 2014. (Crawford Decl, Dkt. No. 40-7, ¶ 11; Opp. Ex. 2, Dkt. No. 40-8.) In a deposition, a representative of Defendant stated that Defendant denied Plaintiffs request on the basis of its policy on investigational treatments, not on the grounds of medical necessity. (Compl. Ex. 7 at 151-152.) Defendant’s representative also stated that it handled Plaintiffs appeal in accordance with its policies and that it applies the same policy to all members’ requests for ADR. (Id. at 155— 159.)

Defendant states that its medical polices are created by the Blue Shield Medical Policy Committee, which is composed of licensed physicians employed by Defendant as medical directors. (Allen Decl. ¶4.) Defendant states that its medical policies are reviewed periodically as necessary and that most medical policies are reviewed at least once every two years. (Id.)

Plaintiff alleges that the FDA first approved a type of ADR in 2004 and that the type of ADR sought by Plaintiff was approved in 2006. (Compl. ¶¶ 10-11.) The definition of “investigational” used in Defendant’s medical policies states that services and supplies that receive government authorization may still be investigational. (Compl. Ex. 5 at 110, Ex. 6 at 122.)

Plaintiff has filed a putative class action against Blue Cross, asserting two claims: (1) Clarification of Rights under an ERISA Plan, pursuant to 29 U.S.C. § 1132(a)(1)(B) ; and (2) Breach of Fiduciary Duty under an ERISA Plan, pursuant to 29 U.S.C. § 1132(a)(3). (See generally Compl.)

Plaintiff submitted a revised class definition in his Motion for Class Certification. Plaintiff proposes certifying a class defined as:

All persons covered under private employer plans with Blue Shield of California who at any time from April 18, 2010 were advised or learned, or will be advised or learn in the future, that Blue Shield deems lumbar artificial disc replacement (ADR) surgery for their back conditions “investiga-tional” and excluded from coverage. (Mot. at 8.)

Plaintiff seeks (1) benefits Defendant has denied Plaintiff, with interest; (2) a clarification of rights to future benefits under the plan for all class members; (3) an injunction requiring Defendant to retract its classification of ADR as investigational, inform all plan members of the retraction who have had requests for ADR denied, and re-review all improperly denied claims; (4) an accounting and disgorgement of any profits made through improper denial of claims; (5) attorney’s fees; and (6) other relief as the Court deems just and proper. (Compl. at 8-9.)

[617]*617II. LEGAL STANDARD

The party seeking class certification bears the burden of showing that each of the four requirements of Rule 23(a) and at least one of the requirements of Rule 23(b) are met. See Meyer v. Portfolio Recovery Assocs., LLC, 707 F.3d 1036, 1041 (9th Cir. 2012); Hanon v. Dataprods. Corp., 976 F.2d 497, 508-09 (9th Cir.1992). In determining whether to certify a class, a court must conduct a “rigorous analysis” to determine whether the party seeking certification has met the prerequisites of Rule 23 of the Federal Rules of Civil Procedure. Valentino v. Carter-Wallace, Inc., 97 F.3d 1227, 1233 (9th Cir.1996).

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Cite This Page — Counsel Stack

Bluebook (online)
309 F.R.D. 612, 2015 U.S. Dist. LEXIS 97261, 2015 WL 4477721, Counsel Stack Legal Research, https://law.counselstack.com/opinion/escalante-v-california-physicians-service-cacd-2015.